Tag Archives: autoimmune disorders

October, 2017

September, 2017

July, 2017

November, 2016

  • 30 November

    Momenta’s Humira Biosimilar Succeeds in Late-Stage Psoriasis Study

    CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the confirmatory Phase 3 clinical study of M923, a biosimilar HUMIRA® (adalimumab) candidate developed in collaboration with Baxalta, now part of Shire plc, in patients with moderate-to-severe chronic plaque psoriasis, met its primary endpoint. The proportion …

October, 2016

March, 2016

  • 18 March

    Vitae Pharmaceuticals Psoriasis Drug Succeeds in Phase 2a Trial

    FORT WASHINGTON, Pa., March 16, 2016 (GLOBE NEWSWIRE) — Vitae Pharmaceuticals, Inc.(NASDAQ:VTAE), a clinical-stage biotechnology company, today announced positive top-line results from its Phase 2a proof-of-concept clinical trial of VTP-43742 in psoriatic patients. VTP-43742 is Vitae’s wholly owned, first-in-class, orally active RORγt inhibitor with the potential to transform the treatment …

November, 2015

June, 2015